2seventy bio clinical trials
Acquired by Bristol-Myers Squibb, May 13, 2025 · source ↗
The registry lists 1 studies whose lead sponsor is 2seventy bio. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 7, 2023.
Before and after it joined Bristol-Myers Squibb
- First submitted before 2seventy bio became part of Bristol-Myers Squibb
- 1
- First submitted after 2seventy bio became part of Bristol-Myers Squibb
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- 2seventy bio1 study
Something wrong with this grouping? Tell us on the Bristol-Myers Squibb page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Bristol-Myers Squibb studies →
- Study of bb21217 in Multiple MyelomaCompletedNCT03274219Phase 1
Sponsor listed in the registry: 2seventy bio · First submitted before 2seventy bio became part of Bristol-Myers Squibb